If data could speak, it would tell us that 1.9 billion people will be living with obesity by the year 20351. Rapidly increasing and affecting millions of lives, obesity, is still largely regarded as an individual burden with less than 2% of people in need receiving treatment2.
At Novo Nordisk, we've been changing the lives of people living with diabetes for 100 years. Now, we're determined to change the story for people living with obesity all over the world - pioneering new research, changing the stigma, and giving people access to the treatment they deserve. With first-of-their-kind products already on the market, we're forging a path toward a more hopeful tomorrow for millions. We're ambitious, curious and passionate challengers of the status quo. Are you one of us?
If so, then join us on our journey and make your mark within our Obesity Therapy Area.
Transform perceptions and eradicate deep-rooted stigma while collaborating and communicating with innovators across the business in a new area of pharmaceutical discovery.
Obesity is a complex chronic disease. But with the right care, people with obesity can achieve sustained weight loss that really makes a difference to their health.